Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sadafumi Omura is active.

Publication


Featured researches published by Sadafumi Omura.


Applied Microbiology and Biotechnology | 1992

Transformation of vitamin D3 to 1α,25-dihydroxyvitamin D3 via 25-hydroxyvitamin D3 using Amycolata sp. strains

Joji Sasaki; Akiko Miyazaki; Mika Saito; Takashi Adachi; Kazutoshi Mizoue; Kazunori Hanada; Sadafumi Omura

To enzymatically synthesize active metabolites of vitamin D3, we screened about 500 bacterial strains and 450 fungal strains, of which 12 strains were able to convert vitamin D3 to 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3] via 25-hyroxyvitamin D3 [25(OH)D3]. The conversion activity was only detected in strains belonging to the genus Amycolata among all the organisms tested. A preparative-scale conversion of vitamin D3 to 25(OH)D3 and 1α,25(OH)2D3 in a 200-1 tank fermentor using A. autotrophica FERM BP-1573 was accomplished, yielding 8.3 mg 25(OH)D3/l culture and 0.17 mg 1α,25(OH)2D3/l culture. A related compound, vitamin D2, could be also converted to 25-hydroxyvitamin D2 and 1α,25-dihydroxyvitamin D2 using the same strain. The cytochrome P-450 of FERM BP-1573 was detected by reduced CO difference spectra in whole-cell suspensions. Vitamin D3 in the culture induced cytochrome P-450 and the conversion activity simultaneously, suggesting that the hydroxylation at C-25 of vitamin D3 and at C-1 of 25(OH)D3 originates from cytochrome P-450.


Journal of Fermentation and Bioengineering | 1994

Application of cyclodextrin to microbial transformation of vitamin D3 to 25-hydroxyvitamin D3 and 1α,25-dihydroxyvitamin D3

Koji Takeda; Toru Asou; Atushi Matsuda; Kiyoshi Kimura; Kazuhiko Okamura; Rokuro Okamoto; Joji Sasaki; Takashi Adachi; Sadafumi Omura

Abstract Amycolata autotrophica converts vitamin D3(VD3) to 1α,25-dihydroxyvitamin D3(1α,25(OH)2VD3) via 25-hydroxyvitamin D3(25(OH)VD3) by hydroxylation of VD3 at C-25 and C-1. In this microbial hydroxylation, it was found that cyclodextrin (CD) had the ability to enhance the hydroxylation of VD3. Addition of partially-methylated-β-cyclodextrin (PMCD) increased the productivity of 25(OH)VD3 about seven-fold compared to that without CD. Combined use of PMCD and γ-CD increased the production of 1α,25(OH)2VD3 in a tank fermentor about sixteen-fold compared to that without CD.


Microbiology and Immunology | 1984

Effect of E-64, Thiol Protease Inhibitor, on the Secondary Anti-SRBC Response In Vitro

Toshiro Amamoto; Tadayasu Okazaki; Toshi Komurasaki; Kazunori Hanada; Sadafumi Omura

E‐64, L‐trans‐epoxysuccinyl‐leucylamido (4‐guanidino) butane, a specific inhibitor of thiol proteases originally isolated from the culture of a fungus, was examined in connection with the immune responses to the splenocytes of mice.


The Journal of Antibiotics | 1984

Chemical modification of erythromycins. I: Synthesis and antibacterial activity of 6-O-methylerythromycins A

Shigeo Morimoto; Yoko Takahashi; Yoshiaki Watanabe; Sadafumi Omura


Journal of pharmacobio-dynamics | 1986

IN VITRO AND IN VIVO INHIBITION OF CYSTEINE PROTEINASES BY EST, A NEW ANALOG OF E-64

Masaharu Tamai; Kazuko Matsumoto; Sadafumi Omura; Ikuo Koyama; Yasuo Ozawa; Kazunori Hanada


Archive | 1981

Novel erythromycin compounds

Yoshiaki Watanabe; Shigeo Morimoto; Sadafumi Omura


Journal of Biochemistry | 1981

Papain Inhibitions by Optically Active E-64 Analogs

Masaharu Tamai; Kazunori Hanada; Takashi Adachi; Kiyoshi Oguma; Keiko Kashiwagi; Sadafumi Omura; Masahiro Ohzeki


The Journal of Antibiotics | 1990

Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A.

Shigeo Morimoto; Yoko Misawa; Takashi Adachi; Takatoshi Nagate; Yoshiaki Watanabe; Sadafumi Omura


The Journal of Antibiotics | 1982

Studies on the alpha-glucoside hydrolase inhibitor, adiposin. I. Isolation and physicochemical properties.

Shinjuro Namiki; Kunio Kangouri; Takatoshi Nagate; Hiroshi Hara; Kazuhiko Sugita; Sadafumi Omura


Planta Medica | 1989

New hepatoprotective triterpenes from Canarium album

Masaharu Tamai; Naoharu Watanabe; Mayumi Someya; Hideaki Kondoh; Sadafumi Omura; Zhang Pei Ling; Rao Chang; Chen Wei Ming

Collaboration


Dive into the Sadafumi Omura's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Taku Mizutani

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Shigeo Morimoto

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Masaharu Tamai

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shinjuro Namiki

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Akira Kawashima

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kazunori Hanada

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge